Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31302979 | 0.78 | SMN1; SMN2 (0.45) | SMN1; SMN2TSHRALDH1A1MAPK1HTT | |
| SCHEMBL13052086 | 0.78 | MEN1 (0.35) | SMN1; SMN2ALDH1A1HTTPOLBHPGD | |
| SCHEMBL7229299 | 0.76 | SMN1; SMN2 (0.37) | OPRM1OPRD1SMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL1706642 | 0.76 | ALDH1A1 (0.48) | SMN1; SMN2TSHRALDH1A1MAPK1HTT | |
| SCHEMBL12928715 | 0.76 | SMN1; SMN2 (0.48) | SMN1; SMN2TSHRALDH1A1MAPK1HTT | |
| SCHEMBL16975534 | 0.75 | MAPT (0.56) | SMN1; SMN2TSHRALDH1A1MAPK1USP2 | |
| Hydrochloric Acid SCHEMBL25407374 | 0.74 | ALDH1A1 (0.47) | SMN1; SMN2TSHRALDH1A1MAPK1HTT | |
| SCHEMBL4256867 | 0.74 | ALDH1A1 (0.47) | SMN1; SMN2TSHRALDH1A1MAPK1HTT | |
| SCHEMBL22360354 | 0.74 | SMN1; SMN2 (0.45) | SMN1; SMN2TSHRALDH1A1MAPK1HTT | |
| SCHEMBL2862694 | 0.74 | SMN1; SMN2 (0.45) | SMN1; SMN2TSHRALDH1A1MAPK1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114478436-B | Alpha-aminoketone photoinitiator modified by containing polymerizable itaconic acid group, and preparation method and application thereof | 浙江扬帆新材料股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-114478436-B | Alpha-aminoketone photoinitiator modified by containing polymerizable itaconic acid group, and preparation method and application thereof | 浙江扬帆新材料股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| US-7838110-B2 | Aziridine-functional photoactive crosslinking compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-11-23 | — | — | US | disclosed |
| US-20100137469-A1 | AZIRIDINE-FUNCTIONAL PHOTOACTIVE CROSSLINKING COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137469-A1 | AZIRIDINE-FUNCTIONAL PHOTOACTIVE CROSSLINKING COMPOUNDS | PTMA, PAM, AAAS | OPRM1 1464/4885OPRD1 564/4885SMN1; SMN2 3912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.